AOP Health has launched the phase 1 clinical trial SERHEMA-1 to evaluate the first-in-class investigative drug AOP208 in patients with acute myeloid leukaemia (...

Alithea Genomics, a pioneering biotech company specialising in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to broaden ac...

Bruker Corporation announced the commissioning of a novel BioSpec™ 18 Tesla preclinical MRI, the world's highest-field horizontal-bore MRI system, at the Champal...

At ASM Microbe 2026, Bruker Corporation's Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations acros...

Positive pooled long-term data from Phase II interim results for Boehringer Ingelheim's verducatib, presented at the recent ATS 2026 International Conference, de...

Haga Bioscience (HAGA.BIO), a Swedish spatial biology startup, today announced it has closed a SEK 20.9 million (approximately USD 2.3 million) oversubscribed Se...

CRDMO successfully scaled and transferred Renaissance Pharma's lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblasto...

Dedicated R&D space to accelerate development of at-home testing to provide discreet, simple and fast solutions for sexually transmitted infections ONE B...

Designed to adapt to diverse biopharma development needs, and enabled by close collaboration and parallel execution, the partnership introduces a flexible global...

The hereditary angioedema (HAE) pharmaceutical landscape is evolving at an unprecedented speed. Following a surge of approvals in recent years, the market is now...